NKH 477

CAS : 138605-00-2

Ref. 3D-BN178886

Informations sur le produit

• Nom: NKH 477
• Synonymes: (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-5-yl acetate, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-6-yl 4-methylpentanoate hydrochloride (1:1), (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxododecahydro-1H-benzo[f]chromen-6-yl N,N-dimethyl-beta-alaninate hydrochloride (1:1), (3R-(3-Alpha,4A-Beta,5-Beta,6-Beta,6A-Alpha,10-Alpha,10A-Beta,10B-Alpha))-Id, 1H-Naphtho[2,1-b]pyran, β-alanine deriv., 6-(3-Dimethylaminopropionyl)forskolin hydrochloride, Adehl, Adehl (TN), Beta-Alanine,N,N-Dimethyl-,5-(Acetyloxy)-3-Ethenyldodecahydro-10,10B-Dihydrox, Colforsin dapropate hydrochloride, Colforsindapropatehydrochloride, N,N-Dimethyl-(3R,4aR,5S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-, Nkh 477, Y-3,4A,7,7,10A-Pentamethyl-1-Oxo-1H-Naphtho(2,1-B)Pyran-6-Ylester,Hydrochlor, β-Alanine, N,N-dimethyl-, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-b]pyran-6-yl ester, hydrochloride, β-Alanine, N,N-dimethyl-, (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-b]pyran-6-yl ester, hydrochloride (1:1), β-Alanine, N,N-dimethyl-, 5-(acetyloxy)-3-ethenyldodecahydro-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-1H-naphtho[2,1-b]pyran-6-yl ester, hydrochloride, [3R-(3α,4aβ,5β,6β,6aα,10α,10aβ,10bα)]-

Description

NKH 477 is a drug that has been shown to increase the amount of calcium in the cytosol of cells. It has been found to be effective at low doses, which may be due to its ability to activate phospholipase C and stimulate the release of calcium from intracellular stores. NKH477 is an analogue of glucagon-like peptide 1 (GLP-1) and has been shown to have similar effects on cardiac muscle, but with less effect on pancreatic beta cells.
The effect of NKH 477 on cardiac muscle was studied in vitro using papillary muscle strips from guinea pig hearts. The drug was shown to cause relaxation of the muscles by stimulating ryanodine receptors, which are responsible for releasing calcium from intracellular stores. This drug may also have potential as a treatment for type 2 diabetes mellitus by activating GLP-1 receptors in the pancreas.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 546.09 g/mol
• Formule: C₂₇H₄₄ClNO₈
• Degré de pureté: Min. 95%